Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Liabilities and Shareholders Equity (2016 - 2025)

Nu-Med Plus' Liabilities and Shareholders Equity history spans 11 years, with the latest figure at $22163.0 for Q4 2021.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 96.02% to $22163.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $447542.0, a 78.75% decrease, with the full-year FY2021 number at $22163.0, down 96.02% from a year prior.
  • Liabilities and Shareholders Equity hit $22163.0 in Q4 2021 for Nu-Med Plus, down from $51236.0 in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for NUMD hit a ceiling of $852238.0 in Q2 2020 and a floor of $22163.0 in Q4 2021.
  • Historically, Liabilities and Shareholders Equity has averaged $303035.6 across 5 years, with a median of $321115.0 in 2017.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 1514.55% in 2020 and later tumbled 96.02% in 2021.
  • Tracing NUMD's Liabilities and Shareholders Equity over 5 years: stood at $406719.0 in 2017, then increased by 4.01% to $423016.0 in 2018, then plummeted by 89.18% to $45779.0 in 2019, then soared by 1117.01% to $557135.0 in 2020, then tumbled by 96.02% to $22163.0 in 2021.
  • Business Quant data shows Liabilities and Shareholders Equity for NUMD at $22163.0 in Q4 2021, $51236.0 in Q3 2021, and $89130.0 in Q2 2021.